Today: August 29, 2015, 11:03 pm

Cuba Pharmaceuticals and Healthcare Market: New market analysis published
Cuba Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on 2014-04-02 20:45:01
The special economic zone allows Cuba to have greater openness in parts of its state without the immediate danger of risking its deeply rooted communist system. Cuba has also taken other tacit admissions of major structural changes to reform its economy and become more open to the outside world.

However, the US trade embargo remains a major hindrance for foreign drugmakers to capitalise on Cuba´s strong potential in the pharmaceutical and healthcare industry.

Headline Expenditure Projections:

- Pharmaceuticals: CUP1.28bn (US$1.28bn) in 2012 to CUP1.35bn (US$1.35bn) in 2013; +5.1% in local currency terms and US dollar terms.

- Healthcare: CUP7.32bn (US$7.32bn) in 2012 to CUP7.84bn (US$7.84bn) in 2013; +7.1% in local currency terms and US dollar terms.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.